Stanford researchers have developed a new therapeutic approach to protect neurons and promote axon regeneration by restoring mitochondrial transport within axons, a key process disrupted in many neurodegenerative diseases.
Stanford researchers have developed a novel technique, enabling specific labeling and purification of regenerating and non-regenerating retinal ganglion cells from the same animals with the same genetic background/modification/injuries.